Sources | Names Used |
---|---|
CTRPv2 | triazolothiadiazine |
PharmacoGx | triazolothiadiazine |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SLC25A2 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.0007 |
mRNA | PGBD1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
mRNA | MAP1S | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0007 |
mRNA | GLOD4 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0007 |
mRNA | SYT1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
mRNA | ANAPC5 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
mRNA | RAPGEF5 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0007 |
mRNA | PRRC2A | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
mRNA | FANCA | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
mRNA | C2orf42 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |